
NYSE:GL
This summary was created by AI, based on 7 opinions in the last 12 months.
Globe Life Inc. (GL-N) is widely regarded as a strong investment choice among analysts, particularly Michael O'Reilly, who has reiterated its status as a TOP PICK on multiple occasions. The company has shown impressive financial growth, reporting a 20% increase in net income, coupled with a robust 20% return on equity (ROE). Analysts noted the stock’s affordability, trading at around 12 times earnings and 2.3 times book value, solidifying its position as a compelling option for investors. With ongoing share buybacks and a gradual increase in book value per share, Globe Life presents a desirable opportunity, especially during uncertain market conditions. Price targets across various reviews range from $168.70 to $215, indicating strong upside potential; hence, the analysts recommend a strategic stop-loss to mitigate risks.
Globe Life Inc. is a American stock, trading under the symbol GL (previously GL-N on Stockchase) on the New York Stock Exchange (GL). It is usually referred to as NYSE:GL or GL
In the last year, 7 stock analysts issued a Buy, Sell, or Hold rating on GL (previously GL-N on Stockchase). 7 analysts recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is TOP PICK. Read the latest stock experts' ratings for Globe Life Inc..
Globe Life Inc. was recommended as a Top Pick by The Panic-Proof Portfolio (Stockchase Research) on 2026-08-13. Read the latest stock experts ratings for Globe Life Inc..
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Globe Life Inc..
Globe Life Inc. is covered by Stockchase experts and is worth watching.
On 2026-09-04, Globe Life Inc. (GL) stock closed at a price of $174.32.
We again reiterate this insurance provider as a TOP PICK. Recently reported earnings showed a 20% increase in net income. It trades at 12x earnings, 2.3x book and supports a 20% ROE. We continue to recommend a stop at $165, looking to achieve $214 -- upside potential of 18%. Yield 0.6%
(Analysts’ price target is $195.57)